Connection

JORGE E CORTES to Interleukin-3 Receptor alpha Subunit

This is a "connection" page, showing publications JORGE E CORTES has written about Interleukin-3 Receptor alpha Subunit.
  1. SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia. Br J Haematol. 2014 Sep; 166(6):862-74.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.